E.U. Targets Boehringer For Misuse Of Patent System
The proceedings, which were initiated March 22, “concern misuse of the patent system in order to exclude potential competition in the area of chronic obstructive pulmonary disease (COPD) drugs,” the Commission said.
The Commission also mentioned Almirall Prodesfarma as part of its notice, but did not say how the Spanish drug...
To view the full article, register now.